NPCE
HEALTHCARENeuroPace Inc
$18.12+1.08 (+6.34%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving NPCE Today?
No stock-specific AI insight has been generated for NPCE yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$7.56$19.44
$18.12
Fundamentals
Market Cap$615M
P/E Ratio—
EPS$-0.66
Dividend Yield—
Dividend / Share—
ROE-1.6%
Profit Margin-0.2%
Debt / Equity—
Trading
Volume381K
Avg Volume (10D)—
Shares Outstanding34.0M
NPCE News
20 articles- NeuroPace (NPCE) Moves 6.3% Higher: Will This Strength Last?Yahoo Finance·May 7, 2026
- NeuroPace to Report First Quarter 2026 Financial Results on May 12, 2026Yahoo Finance·Apr 29, 2026
- NeuroPace Highlights Expanding Clinical Evidence Leadership with Published 3-Year Post-Approval Study (PAS) Results in Neurology and NAUTILUS Presentation at AAN 2026Yahoo Finance·Apr 27, 2026
- NeuroPace to Present at the 25th Annual Needham Virtual Healthcare ConferenceYahoo Finance·Apr 10, 2026
- NeuroPace (NPCE) Up 0.9% Since Last Earnings Report: Can It Continue?Yahoo Finance·Apr 2, 2026
- Here's Why You Should Add NeuroPace Stock to Your Portfolio NowYahoo Finance·Apr 2, 2026
- Wall Street Analysts See a 41.29% Upside in NeuroPace (NPCE): Can the Stock Really Move This High?Yahoo Finance·Apr 2, 2026
- How Shifting Margin Assumptions Are Rewriting The NeuroPace (NPCE) Investment NarrativeYahoo Finance·Apr 1, 2026
- How The NeuroPace (NPCE) Story Is Shifting As Analysts Refresh Valuation AssumptionsYahoo Finance·Mar 18, 2026
- Key Catalysts That Will Likely Drive Prospects for NPCE Stock in 2026Yahoo Finance·Mar 10, 2026
- NPCE RNS System Explained: Growth Drivers and Setup for 2026Yahoo Finance·Mar 10, 2026
- NeuroPace's Seizure ID and New Indication Could Expand RNS DemandYahoo Finance·Mar 10, 2026
- NeuroPace to Present at the Leerink Global Healthcare ConferenceYahoo Finance·Mar 5, 2026
- Why NeuroPace Stock Was Inching Higher on WednesdayMotley Fool·Mar 4, 2026
- NeuroPace Inc (NPCE) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...Yahoo Finance·Mar 4, 2026
- NeuroPace (NPCE) Q4 2025 Earnings Call TranscriptMotley Fool·Mar 3, 2026
- NeuroPace Q4 Earnings Call HighlightsMarketbeat·Mar 3, 2026
- NeuroPace, Inc. (NPCE) Reports Q4 Loss, Beats Revenue EstimatesYahoo Finance·Mar 3, 2026
- NeuroPace Inc.: Q4 Earnings SnapshotYahoo Finance·Mar 3, 2026
- NeuroPace Reports Fourth Quarter and Full Year 2025 Financial Results and Reiterates 2026 OutlookYahoo Finance·Mar 3, 2026
All 20 articles loaded
Price Data
Open$17.19
Previous Close$17.04
Day High$17.26
Day Low$16.69
52 Week High$19.44
52 Week Low$7.56
52-Week Range
$7.56$19.44
$18.12
Fundamentals
Market Cap$615M
P/E Ratio—
EPS$-0.66
Dividend Yield—
Dividend / Share—
ROE-1.6%
Profit Margin-0.2%
Debt / Equity—
Trading
Volume381K
Avg Volume (10D)—
Shares Outstanding34.0M
About NeuroPace Inc
NeuroPace, Inc. is a medical device company in the United States. The company is headquartered in Mountain View, California.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—